SEC Form 4 · accession 0001415889-15-000152
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Ann Gray
Director
Period of report
Jan 13, 2015
Accepted (ET)
Jan 15, 2015 · 6:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2015 | M | 4,250 | $11.00 | A | 4,250 | D | |
| Common Stock | Jan 13, 2015 | S | 4,250 | $35.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $11.00 | Jan 13, 2015 | M | 4,250 | D | — | Sep 8, 2015 | Common Stock | 4,250 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2014.
- F2100% of the shares subject to the stock option vested and became exercisable on September 9, 2006.